BLB-logo-negativo
PCLS
BLB OFFERS THE POSSIBILITY TO TEST YOUR COMPOUNDS IN HUMAN PCLS

PCLS are generated rapidly upon donation allowing reliable assessment of compounds efficacy. Upon incubation, tissues are processed for a variety of endpoints including gene and protein expression, immunohistochemistry and immunofluorescence. Media is also collected for the assessment of secreted factors. Let us analyze the effects of your compounds in healthy or diseased human PCLS.

The complete pre-clinical Solution

EXOLIVER®

BLB offers you the possibility to test your drug candidates in a human liver biological system: the unique and patent-protected ExoLiver platform
MORE INFO

TISSUES

BLB gives you the possibility to analyze your favourite gene or protein in liver tissue obtained from rodents and humans
MORE INFO

PCLS

Screen your compounds in fresh precision-cut liver slices
MORE INFO

ORGAN
ON A CHIP

BLB offers high-quality services to create tailored organ on a chip platforms for preclinical human disease modelling
MORE INFO

RODENT
MODELS

BLB provides research services using topquality pre-clinical models of liver disease, including liver cirrhosis, cholestatic liver disease & NASH
MORE INFO

BIOINFORMATICS

Unlock your research with BLB bioinformatic services
MORE INFO

LIVER
CELLS

BLB develops analysis with highly pure and viable rodent and human primary liver cells
MORE INFO

STRATEGIC
CONSULTANCY

The virtuous combination of having deep experience in both pre-clinical and clinical phases of liver research
MORE INFO

BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.

BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers

If you are interested in joining the company that is changing the pre-clinical research in the fields of hepatology and toxicology, please contact us